selected publications
- A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or other DNA damage repair system variants. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 2024 Academic Article GET IT
- Completion Rate and Positive Results Reporting Among Immunotherapy Trials in Breast Cancer, 2004-2023. JAMA network open. 2024 Academic Article GET IT
- Management of Trastuzumab Deruxtecan-related nausea and vomiting in real-world practice. Frontiers in oncology. 2024 Academic Article GET IT
- Re: Which Patients with Metastatic Hormone-sensitive Prostate Cancer Benefit from Docetaxel: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Trials. European urology. 2023 Letter GET IT
-
Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment response.
European journal of cancer.
2023
Academic Article
GET IT
Times cited: 3 -
Understanding the causes of recurrent HCC after liver resection and radiofrequency ablation.
Expert review of anticancer therapy.
2023
Review
GET IT
Times cited: 2 -
Tissue- and liquid biopsy-based biomarkers for immunotherapy in breast cancer.
Breast (Edinburgh, Scotland).
2023
Review
GET IT
Times cited: 7 -
Lack of efficacy of Interferon β-1a in COVID-19 patients with mild to moderate pneumonia.
European journal of internal medicine.
2022
Letter
GET IT
Times cited: 1 -
Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial.
Trials.
2020
Academic Article
GET IT
Times cited: 26 -
Molecular Profile of Advanced Non-Small Cell Lung Cancers in Octogenarians: The Door to Precision Medicine in Elderly Patients.
Journal of clinical medicine.
2019
Academic Article
GET IT
Times cited: 9